Oct 4, 2021
Sep 22, 2021
Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science
Sep 2, 2021
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
Sep 1, 2021
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.
Aug 25, 2021
Renovacor Announces the Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
Jul 19, 2021